ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Superpure Echinacea Purpurea Juice Extract

Also known as: Echinacea purpurea, Purple Coneflower, American Coneflower

Overview

Echinacea purpurea, commonly known as Purple Coneflower, is a flowering plant native to North America. It is widely used as an herbal supplement, primarily for its purported immune-enhancing properties. The plant contains bioactive compounds, such as chicoric acid, which are believed to contribute to its immunomodulatory effects. Echinacea is available in various forms, including juice extracts, capsules, and dried extracts. It is commonly used to prevent and treat upper respiratory tract infections (URTIs). Research on Echinacea is ongoing, with systematic reviews and meta-analyses providing mixed evidence regarding its effectiveness. Some studies suggest benefits in reducing URTI incidence and duration, while others show less significant effects. The quality of available evidence varies, but Echinacea remains a popular choice for immune support.

Benefits

Echinacea purpurea is primarily known for its potential to reduce the incidence and duration of upper respiratory tract infections (URTIs). A meta-analysis indicated a risk ratio of 0.78 for preventing URTIs, suggesting a potential preventive effect. Additionally, some evidence suggests that Echinacea may reduce the need for antibiotics by preventing recurrent respiratory infections. Children may experience reduced treatment duration for URTIs, although more research is necessary to confirm this benefit. The effect size for reducing URTI duration is generally small to moderate, with a mean difference of approximately -0.45 days. Benefits may be observed within a few days of supplementation, but long-term effects are less clear. The effectiveness of Echinacea can vary depending on the specific preparation and individual factors.

How it works

Echinacea purpurea is believed to modulate immune function by enhancing cytokine production and macrophage activity. It interacts with the immune system, potentially boosting its response to infections. Chicoric acid, a key component of Echinacea, may influence immune function by modulating cytokine levels. The bioavailability of Echinacea compounds varies, with some studies suggesting that extracts with higher chicoric acid content may be more effective. These mechanisms collectively contribute to Echinacea's potential to support immune function and reduce the severity and duration of upper respiratory infections.

Side effects

Echinacea purpurea is generally considered safe for short-term use, but long-term safety data is limited. Common side effects include mild gastrointestinal disturbances and allergic reactions. Uncommon side effects may include more severe allergic reactions. Anaphylaxis is a rare but possible side effect. There are potential interactions with immunosuppressants, although evidence is limited. Individuals with autoimmune diseases should consult a healthcare provider before use. Pregnant or breastfeeding women should exercise caution due to limited safety data. It is important to discontinue use if any adverse reactions occur and to consult with a healthcare professional before starting Echinacea, especially if you have underlying health conditions or are taking other medications.

Dosage

The minimum effective dose of Echinacea purpurea is not well established, but typically ranges from 300 to 500 mg of extract per day. Optimal dosage ranges vary by product and desired effect, often between 300 to 1000 mg per day. The maximum safe dose is generally considered to be up to 1000 mg per day, although long-term safety at higher doses is unclear. It is best taken at the onset of symptoms or as a preventive measure. Juice extracts may offer different bioavailability compared to capsules or dried extracts. Bioavailability can vary based on the specific extract composition. Consult with a healthcare provider to determine the appropriate dosage for your specific needs.

FAQs

How should I use Echinacea?

Echinacea should be used under the guidance of a healthcare provider, especially for chronic conditions. It is generally safe but may interact with certain medications. Take it consistently for preventive effects, starting at the onset of symptoms.

Is Echinacea safe?

Echinacea is generally safe, but may interact with certain medications. Common side effects are mild gastrointestinal issues or allergic reactions. Consult a healthcare provider if you have autoimmune conditions or are pregnant/breastfeeding.

When should I take Echinacea?

Echinacea is best taken at the first sign of cold or flu symptoms or consistently as a preventive measure during cold and flu season. Follow the dosage instructions on the product label or as directed by your healthcare provider.

What results can I expect from taking Echinacea?

Echinacea may reduce the incidence and duration of upper respiratory tract infections, though results vary. It is not a cure for infections and should be used alongside conventional treatments when necessary. Individual responses can differ.

Is Echinacea a cure for infections?

No, Echinacea is not a cure for infections. It should be used alongside conventional treatments when necessary. It may help reduce the severity and duration of symptoms, but it does not replace medical care.

Research Sources

  • https://pubmed.ncbi.nlm.nih.gov/31126553/ – This systematic review and meta-analysis found that Echinacea preparations may reduce the incidence of URTIs, with a risk ratio of 0.78 (95% CI 0.68-0.88). The study suggests a potential preventive effect of Echinacea on upper respiratory tract infections based on the analyzed data.
  • https://www.mdpi.com/2079-6382/13/4/364 – This meta-analysis suggests that Echinacea could reduce recurrent respiratory infections and antibiotic use. The findings indicate that Echinacea may have a role in preventing recurrent respiratory infections, potentially decreasing the need for antibiotic treatments.
  • https://sciety.org/articles/activity/10.20944/preprints202502.2015.v1 – This systematic review evaluating E. purpurea in children found it effective in reducing URTI treatment duration, though more research is needed. The study suggests that E. purpurea may be beneficial in reducing the duration of upper respiratory tract infections in children, but further research is recommended to confirm these findings.
  • https://www.preprints.org/manuscript/202502.2015/v1 – This is a preprint version of a systematic review evaluating E. purpurea in children and found it effective in reducing URTI treatment duration, though more research is needed. The study suggests that E. purpurea may be beneficial in reducing the duration of upper respiratory tract infections in children, but further research is recommended to confirm these findings.
  • https://pubmed.ncbi.nlm.nih.gov/37585723/ – This study investigates the immunomodulatory effects of Echinacea purpurea. It provides insights into how Echinacea purpurea may influence immune function, potentially enhancing the body's response to infections.